Use of recombinant activated factor VII for massive postpartum hemorrhage
Authors:
Open Access
- 1 October 2007
- journal article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 86 (10) , 1200-1206
Abstract
Objective. We hypothesised that patients with massive postpartum hemorrhage (PPH), defined as blood loss >1,500 ml, may benefit from the use of activated recombinant factor VII (rFVIIa). Design. Retrospective cohort study. Setting. Department of Obstetrics & Gynaecology, Dow University of Health Sciences. Population. Thirty‐four women with a diagnosis of massive PPH. Methods. All patients with PPH who were admitted to the Department of Obstetrics & Gynecology and Surgical Intensive Care Unit of Civil Hospital Karachi, Pakistan, were included in the study. From March 2005 to October 2006, 34 patients fulfilled the criteria of massive PPH, of which 18 received rFVIIa to control bleeding, and 16 patients did not. Availability and cost of rFVIIa were the factors in drug allocation. Main outcome measures. Maternal mortality, correction of coagulopathy, the amount of blood products transfused and preservation of fertility. Results. Patients receiving rFVIIa had lower maternal mortality (5/18, 28% versus 8/16, 50%, OR: 0.04 (0.002, 0.83)), and received a lower number of packed red cell transfusions (4.0±4.46 versus 9.61±6.7, p value 0.007), against the comparison group. Patients receiving rFVIIa had lower activated partial thromboplastin (median: 13.0; 25–75th percentile: −25.0, −8.0, signed rank pConclusion. Activated recombinant factor VII can be a life‐saving drug in patients with massive PPH.Keywords
This publication has 21 references indexed in Scilit:
- Placenta Accreta: A Review of Current Advances in Prenatal DiagnosisPlacenta, 2007
- Recombinant Activated Factor VII in Cardiac Surgery: A Systematic ReviewThe Annals of Thoracic Surgery, 2007
- Recombinant factor VIIa in massive postpartum haemorrhageInternational Journal of Obstetric Anesthesia, 2007
- Use of recombinant activated factor VII in massive obstetric haemorrhageInternational Journal of Obstetric Anesthesia, 2007
- Peripartum hysterectomy for primary postpartum haemorrhage: Incidence and maternal morbidityJournal of Obstetrics and Gynaecology, 2007
- Recombinant factor VIIa and the surgical patientCurrent Opinion in Critical Care, 2006
- Recombinant factor VIIaThrombosis and Haemostasis, 2005
- The use of recombinant factor VIIa in the treatment of bleeding disordersBlood, 2004
- Recombinant activated factor VII for the treatment of life-threatening haemorrhageBlood Coagulation & Fibrinolysis, 2003
- Major postpartum haemorrhageCurrent Opinion in Obstetrics and Gynecology, 2001